International Assets Investment Management LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 97.1% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 12,281 shares of the healthcare conglomerate’s stock after selling 413,410 shares during the quarter. International Assets Investment Management LLC’s holdings in UnitedHealth Group were worth $4,485,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of UNH. Wellington Altus USA Inc. raised its stake in shares of UnitedHealth Group by 97.1% in the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 33 shares during the period. Security National Bank of SO Dak purchased a new stake in UnitedHealth Group during the 2nd quarter worth $29,000. Nvwm LLC increased its holdings in UnitedHealth Group by 89.2% in the 3rd quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 33 shares in the last quarter. Aberdeen Wealth Management LLC purchased a new position in UnitedHealth Group in the second quarter valued at about $31,000. Finally, Compass Wealth Management LLC acquired a new position in shares of UnitedHealth Group during the third quarter worth about $29,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Stock Down 0.4%
Shares of UnitedHealth Group stock opened at $394.14 on Friday. The company has a market capitalization of $353.16 billion, a PE ratio of 22.51, a P/E/G ratio of 1.43 and a beta of 0.51. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62. The business has a 50-day moving average of $390.62 and a 200-day moving average of $364.03. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm had revenue of $112.72 billion for the quarter, compared to analysts’ expectations of $111.31 billion. During the same quarter in the prior year, the firm posted $2.59 earnings per share. UnitedHealth Group’s revenue for the quarter was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be given a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend is Monday, December 7th. UnitedHealth Group’s dividend payout ratio is currently 53.00%.
Insider Transactions at UnitedHealth Group
In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. 0.19% of the stock is owned by company insiders.
UnitedHealth Group News Summary
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: ETFs purchased $56.4 million of UNH shares on Nov. 4, a potentially supportive demand signal. ETFs Are Buying UnitedHealth (UNH) on Nov. 4
- Positive Sentiment: UnitedHealth’s Q3 adjusted EPS of $4.69 topped analyst expectations, and a recent earnings analysis said the results bolstered confidence in a margin recovery. UnitedHealth (UNH) Q3 Earnings Lift Confidence In Margin Recovery
- Positive Sentiment: A Zacks article characterized Wall Street analysts’ view of UNH as a Buy, offering a favorable sentiment signal, though the article summary did not cite a specific new rating change. Wall Street Analysts See UnitedHealth (UNH) as a Buy: Should You Invest?
- Positive Sentiment: The company declared a quarterly dividend of $2.32 per share, equivalent to $9.28 annually and a reported yield of 2.3%. UnitedHealth Group Declares Quarterly Dividend Of $2.32 Per Share
- Negative Sentiment: Utilization and policy concerns remain an overhang for the company, highlighting uncertainty around medical costs and the regulatory environment. Utilization and Policy Concerns Weigh on UnitedHealth Group Incorporated (UNH)
- Negative Sentiment: Renewed calls for a regulatory review of UnitedHealth’s business scale, alongside warnings that AI could disrupt large healthcare companies, add longer-term risk concerns. UnitedHealth Group (UNH) Draws Breakup Pressure As AI Threat Enters The Story
Analysts Set New Price Targets
Several brokerages have recently weighed in on UNH. Argus upped their target price on UnitedHealth Group from $400.00 to $470.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Bank of America reissued a “buy” rating and set a $450.00 price target on shares of UnitedHealth Group in a research report on Monday, July 20th. Jefferies Financial Group upped their price target on UnitedHealth Group from $401.00 to $490.00 and gave the stock a “buy” rating in a report on Friday, July 17th. Cantor Fitzgerald increased their price objective on shares of UnitedHealth Group from $440.00 to $495.00 and gave the company an “overweight” rating in a research report on Friday, July 17th. Finally, Leerink Partners boosted their target price on shares of UnitedHealth Group from $462.00 to $472.00 and gave the stock an “outperform” rating in a research report on Friday, July 17th. Twenty analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $463.93.
Read Our Latest Analysis on UNH
UnitedHealth Group Company Profile
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid.
Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Founded in 1977 as United HealthCare Corporation, the company is headquartered in Minnetonka, Minnesota.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
